SUMMARY
INTRODUCTION
Myocardial infarction (MI) is a serious consequence of coronary artery disease (CAD), which is the leading cause of death worldwide [1] . MI is a complex and multifactorial disorder that results from the complex interaction between genetics and environmental factors. Recent genome-wide association studies (GWAS) have identified many single-nucleotide polymorphisms (SNPs) associated with CAD and MI across diverse ethnic groups [2] [3] [4] [5] [6] . This association can be used as an im-portant predictive tool to determine an individual's predisposition to heart disease. Thus, validation of these loci in different ethnic populations is important for determining their clinical relevance across diverse populations. Although the prevalence of some SNPs associated with MI have been evaluated in the Chinese Han population [7, 8] , many recent and more prevalently identified SNPs still have not been assessed in this population. The goal of this study was to examine the association between commonly and recently identified SNPs associated with risk of MI within the Chinese Han population.
MATERIALS AND METHODS

Study Population
A total of 549 MI patients, including 399 males and 150 females between the ages of 24 -90 years (mean age, 56.5 ± 13.1 years), were interviewed and recruited from patients admitted to the Department of Cardiology in the First Hospital of Jilin University between August 2008 and August 2011. The incidence of MI in males versus females was found to be consistent with ratios in previous reports [9] . Control subjects for the study included 551 subjects (399 males and 152 females) without a history of CAD and ranged in age from 60 -90 years (mean age, 67.4 ± 6.5 years). Control subjects were recruited from the Physical Examination Center at the First Hospital of Jilin University as part of a cardiovascular health screen that was performed by the Cardiology Department in the First Hospital of Jilin University from August 2008 to August 2011. All of the patient and control subjects were from the Chinese Han population (Table 1) . Informed consent was obtained from all subjects and this study was approved by the Human Ethics Committee at the First Hospital of Jilin University. The smoking and drinking status of the subjects was acquired via information provided on their study questionnaire.
SNP Selection and Genotype Determination
SNPs were selected for screening based on: (i) their reported association with CAD or MI, (ii) their lack of previous association to MI in Chinese or East Asian populations, and (iii) their minor allele frequency (MAF) threshold being above 20% based on statistical power analyses in HapMap-HCB datasets [10] (http:// pngu.mgh.harvard.edu/~purcell/gpc/). Three SNPs were identified to meet these criteria and used for screening. These included: rs1412444 [4] , rs662799 [5] and rs964184 [6] (Table 2) . For SNPs rs1412444 and rs662799, the published risk alleles were found on the opposite strands according to The Genome Reference Consortium Human Genome Build 37.1 (GRCh37.1).
DNA sequence analysis
Genomic DNA was extracted from peripheral blood of subjects using a phenol-chloroform purification method [11] . The concentration and quality of the DNA was measured using a ND-1000 Spectrophotometer (NanoDrop ® , Wilmington, DE, USA). Specific PCR primers were designed for amplification of the SNPs and flanking DNA (Table 3) . PCR reactions were performed on genomic DNA (3 -4 ng/µL) from subjects in a buffer containing 1 x PCR buffer (Applied Biosystems, Foster City, CA, USA), 2.5 mM MgCl 2 , 0.2 mM each dNTP, 0.04 U/µL AmpliTaq ® Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA) and specific primers (0.2 µM forward primer and 0.2 µM reverse primer) using the MJ Mini TM Gradient Thermal Cycler (BioRad, Hercules, CA, USA). The thermal cycling conditions for all PCR reactions were the same and based on Touchdown PCR (Table 4 ) [12] . PCR products were purified by an ExoSAP-IT ® PCR Product Cleanup kit (USB ® ) and ddNTP terminator chain reactions were performed on products for ABI BigDye Terminator v3.1 Cycle Sequencing (Applied Biosystems) using forward and reverse primers for specific SNPs (Table 3) . Sequencing data was collected on an ABI 3130 XL genetic analyzer (Applied Biosystems) and analyzed using Mutation Surveyor v4.0 software (SoftGenetics, State College, PA, USA).
Statistical Analyses
Allelic and genotypic frequencies were compared between MI subjects and controls using the chi-square test. Multiple logistic regression models were employed to analyze the genetic data: codominant1 (major allele homozygotes vs. heterozygotes), codominant2 (major allele homozygotes vs. minor allele homozygotes), dominant (major allele homozygotes vs. heterozygotes and minor allele homozygotes), recessive (major allele homozygotes and heterozygotes vs. minor allele homozygotes), overdominant (major allele homozygotes and minor allele homozygotes vs. heterozygotes), and logadditive (major allele homozygotes vs. heterozygotes vs. minor allele homozygotes). SNPStats [13] (http:// bioinfo.iconcologia.net/snpstats/start.htm) was used to estimate the odds ratios (ORs), their corresponding 95% confidence intervals (CIs), and p-values, adjusting for conventional risk factors under the assumption of different genetic models. The conventional risk factors consist of age (onset of the first event for cases or time of recruitment for controls), gender, smoking and drinking status, hypertension, diabetes, total cholesterol, triglyceride, high-density lipoprotein (HDL) cholesterol, lowdensity lipoprotein (LDL) cholesterol, and body-mass index. Bonferroni correction was performed to obtain further statistical significance. Linkage disequilibrium (LD) and haplotype association analyses were also inferred by using SNPStats. The required case size in each SNP was estimated using the genetic power calculator to obtain the statistical power [10] . A p-value of < 0.05 was considered statistically significant. 
RESULTS
Results are summarized in Table 5 . Although we show that the crude ORs for the SNP rs1412444 are significantly different from MI versus control subjects in a codominant and recessive model with a T/T genotype, no significant differences were observed in any type of genetic model after adjusting for conventional risk factors. Therefore, we did not find an obvious association between SNP rs1412444 and MI risk in the Chinese Han population. However, we showed that the SNPs rs662799 and rs964184 were significantly associated with MI in allelic, codominant, dominant, overdominant, and log-additive models, in addition to being adjusted for conventional risk factors. After Bonferroni correction (p c ), both of the SNPs rs662799 and rs964184 still displayed significant differences between patients with MI and controls in allelic, codominant, dominant, overdominant, and log-additive models. However, the linkage disequilibrium between the SNPs rs662799 and rs964184 (D' = 0.959 and r 2 = 0.652 for MI group; D' = 0.955 and r 2 = 0.658 for control group), suggests that the mechanisms by which both SNPs rs662799 and rs964184 are associated with MI may be different. Detailed examinations of the haplotypes composed of SNPs rs662799 and rs964184 revealed that the GG haplotype (frequency = 21.4%), which consists of the minor allele of each marker, was significantly (OR = 1.39 (range: 1.06 -1.59) and p-value = 0.013) associated with MI in the Chinese Han population. After adjusting for conventional risk factors, the association was found to be even stronger (OR = 1.50 (range: 1.14 -1.97) and p-value = 0.0034). Rs662799 and rs964184 were also found to be significantly associated with triglyceride (TG) levels in our study (p c = 0.0015 for rs662799 and p c = 0.042 for rs964184; Table 6 ). These results imply that the mecha- nism of the association between the two SNPs and MI may be related to the expression of triglyceride associated genes. The sample power was estimated using a genetic power calculator to determine the required sample size [10] . The sample power (α = 0.05/3, genotype relative risk of heterozygotes/rare homozygotes = 1.5/2.25 [14] , 0.208% disease prevalence [9] , number of case for 80% power) of each SNP was calculated to be 0.9889 for rs1412444 (n = 262), 0.9769 for rs662799 (n = 298), and 0.9703 for rs964184 (n = 313). These results suggest that the association analysis from the three examined SNPs was sufficient to achieve statistical confidence.
DISCUSSION
In this study, we screened the Chinese Han population for three SNPs representing variations in three genes previously associated with CAD or MI risk in Caucasian European populations or South Asian populations. The minor allele frequencies of two of the investigated SNPs (rs662799 and rs964184), which were found in the APOA5-ZNF259 gene region located on chromo- In genetic association studies, the mode of inheritance (dominant, additive, and recessive) is usually not known a priori. Making incorrect mode of inheritance assumptions may lead to a substantial loss of power. As a result it is necessary to perform analyses using different kinds of models but, on the other hand, being cognizant that testing all possible models may result in an increased type I error rate. In complex diseases, in which the phenotype is probably determined by many genetic factors acting alone or in combination with environmental parameters, the single variant examined in a genetic association study usually accounts for little hereditability and its small to moderate effect is often obscured by analyses or it may be considered clinically irrelevant. Analyzing data by using the log-additive model only led to a moderate loss of efficiency with smaller sample sizes, even when the true model was dominant or recessive. Also in its favor, the assumed-log-additive model allowed for identifiable parameter estimates more often than did the other models considered, even when inheri- tance was dominant or recessive. In this study, all of the possible genetic models were analyzed for reference, and the log-additive model was ultimately used to assess the association between SNPs and the disease. For SNP association studies, while the SNPs in protein-coding regions may directly determine the genetic variance of phenotype measures, most SNP markers identified in other regions are likely coincident with the already recognized or unknown causal functional variants. This coincidence implies that the mechanisms behind the genetic variations are still not clear, and they remain an elusive challenge in genetics and related fields. Therefore, it is not possible to determine whether the SNPs (rs662799 and rs964184) identified in this study actual-ly have a role in the process of MI or are simply markers for MI. Neither SNP is in a protein-coding region; thus, they are not expected to affect protein structure. However, the haplotype defined by these SNPs may include regulatory elements for the APOA5 gene or adjacent genes, as suggested by Palmen et al. [15] . These SNPs may influence the transcriptional binding sites of the adjacent genes or may interfere with the transcriptional mechanisms without being directly involved in protein regulation. In the study population, the linkage disequilibrium between rs662799 and rs964184 (D' = 0.959 and r 2 = 0.652 for MI group; D' = 0.955 and r 2 = 0.658 for control group), suggests that the mechanism by which rs662799 and rs964184 are associated with MI may be different, although the GG haplotype was still highly associated with MI. Atherogenic dyslipidemia is highly associated with coronary artery disease and is characterized by elevated triglycerides (TG), low high-density lipoprotein cholesterol (HDL-C), and elevated low-density lipoprotein cholesterol (LDL-C). As previously reported [16, 17] , the SNP rs662799 showed a significant association with plasma triglyceride levels. Our study also obtained the same result from subjects from the Chinese Han population. The SNP rs662799 is located in the promoter region of the APOA5 gene (-1131T>C). APOA5 encodes apolipoprotein (apo) AV, which is expressed in the liver [18] and circulates on chylomicrons (CM), very low density lipoproteins (VLDL), and high density lipoproteins (HDL). However, recent studies have suggested that the association between the SNP rs662799 and MI involves triglyceride-independent mechanisms [5] . In terms of the SNP rs964184, it was found to be downstream and proximal to the 3'-UTR of ZNF259. The ZNF259 gene is also found to be located ~1.6 kb upstream of the APOA5-A4-C3-A1 gene cluster. ZNF259 is a protein, which has been shown to regulate cell proliferation and signal transduction [19] , but could also have a potential role in multiple physiological processes. For example, previous studies suggest that ZNF259 contributes to the survival of motor neurons (SMN) complexes [20] . Therefore, a thorough study of the remotely controlled regulatory mechanisms is needed to elucidate whether this SNP could potentially influence the function of these genes. Based on previous studies, the SNP rs964184 showed significant associations with triglyceride (TG) levels in an Asian Indian cohort [21] . The same result was achieved in our study which included subjects from the Chinese Han population. Furthermore, the SNP rs964184 was significantly associated with the HDL-C response to combination therapy with statins and fenofibric acid (FA), with a similar association identified for apolipoprotein A1 (ApoA-I) [22] . Interestingly, the SNP rs964184 also showed a significant association with vitamin E levels, as previously reported [23] . Vitamin E inhibits lipid peroxidation in cell membranes and has been examined for its possible role in preventing chronic diseases including coronary artery disease [24] .
Dyslipidemia is a well-known clinical parameter closely associated with MI. It may be an intermediate phenotype of MI. However, its effect on coronary risk inversely operates through other ethnic-specific genome diversity, because there are many other genetic factors that participate in the susceptibility to MI. In addition, different mechanisms may operate on the effects of SNPs on lipid levels and on coronary risk, and the difference depends in part on the ethnic group [25] . Thus, the association between the SNPs rs662799 and rs964184 and MI should be tested across diverse ethnic groups; however, these SNPs are also reported to be associated with dyslipidemia. One of the differences between this study and other similar genetic association studies is the selection of controls. We chose subjects over 60 years old without a known history of CAD as controls and, therefore, are less likely develop MI. In this way, we could increase the reliability of the results although the collection of control samples was technically more challenging. Future studies aimed to increase sample size and test more SNPs will help to confirm whether known loci have similar effects on risk of MI across diverse ethnic groups.
CONCLUSION
We performed a genetic association study on 549 individuals with MI and 551 controls without a known history of CAD from the Chinese Han population. Three SNPs, which were confirmed to be associated with MI across diverse ethnic groups except the Chinese, were genotyped via a sequencing method. Only two SNPs, rs662799 and rs964184, were found to be significantly associated with MI when they were adjusted for conventional risk factors. Our results indicate that there are both similar and distinct genetic effects of SNPs on the risk of MI between Chinese and other ethnic populations.
